Novozymes A/S (NVZMF) Stock Price & News

Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy. The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations. The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation. As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia

About Novozymes A/S

CEOEster Baiget

Employees11.1K

Founded2000

Headquarters-

SectorSpeciality chemicals

Websitenovonesis.com

Finance

Ask anything


Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale